TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
HUMAN_PWY66-5	superpathway of cholesterol biosynthesis	0.000312455187882609	-8.07104949784606	25	10	0.0909090909090909	110	907	4047,3422,4598,6307,4597,7108,6713,38,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,TM7SF2,SQLE,ACAT1,FDFT1,HMGCR
META_PWY66-5	superpathway of cholesterol biosynthesis	0.000776091339954898	-7.16124033858043	23	9	0.0818181818181818	110	907	4047,3422,4598,6307,4597,6713,38,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,ACAT1,FDFT1,HMGCR
META_PWY66-422	D-galactose degradation V (Leloir pathway)	0.00174124095973162	-6.35315722471051	3	3	0.0272727272727273	110	907	130589,55276,2582	GALM,PGM2,GALE
META_PWY-922	mevalonate pathway I	0.00366901887552312	-5.60783098902612	10	5	0.0454545454545455	110	907	38,3422,4598,4597,3156	ACAT1,IDI1,MVK,MVD,HMGCR
HUMAN_PWY-922	mevalonate pathway	0.00366901887552312	-5.60783098902612	10	5	0.0454545454545455	110	907	38,3422,4598,4597,3156	ACAT1,IDI1,MVK,MVD,HMGCR
HUMAN_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.00942831602179849	-4.66403777497506	12	5	0.0454545454545455	110	907	38,3422,4598,4597,3156	ACAT1,IDI1,MVK,MVD,HMGCR
META_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.00942831602179849	-4.66403777497506	12	5	0.0454545454545455	110	907	38,3422,4598,4597,3156	ACAT1,IDI1,MVK,MVD,HMGCR
HUMAN_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.0138595547242274	-4.27878041241557	13	5	0.0454545454545455	110	907	6713,7108,4047,6307,2222	SQLE,TM7SF2,LSS,MSMO1,FDFT1
HUMAN_PWY66-341	cholesterol biosynthesis I	0.0138595547242274	-4.27878041241557	13	5	0.0454545454545455	110	907	6713,7108,4047,6307,2222	SQLE,TM7SF2,LSS,MSMO1,FDFT1
HUMAN_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.0138595547242274	-4.27878041241557	13	5	0.0454545454545455	110	907	6713,7108,4047,6307,2222	SQLE,TM7SF2,LSS,MSMO1,FDFT1
HUMAN_PWY66-422	D-galactose degradation V (Leloir pathway)	0.0144660953061771	-4.23594762228855	5	3	0.0272727272727273	110	907	130589,55276,2582	GALM,PGM2,GALE
META_PWY-6117	spermine and spermidine degradation I	0.0145909543384771	-4.22735350813582	2	2	0.0181818181818182	110	907	54498,6303	SMOX,SAT1
META_PWY-5340	sulfate activation for sulfonation	0.0145909543384771	-4.22735350813582	2	2	0.0181818181818182	110	907	9060,9061	PAPSS2,PAPSS1
HUMAN_PWY-5340	sulfate activation for sulfonation	0.0145909543384771	-4.22735350813582	2	2	0.0181818181818182	110	907	9060,9061	PAPSS2,PAPSS1
HUMAN_PWY-5670	epoxysqualene biosynthesis	0.0145909543384771	-4.22735350813582	2	2	0.0181818181818182	110	907	6713,2222	SQLE,FDFT1
META_PWY-5670	epoxysqualene biosynthesis	0.0145909543384771	-4.22735350813582	2	2	0.0181818181818182	110	907	6713,2222	SQLE,FDFT1
META_PWY-5327	superpathway of L-lysine degradation	0.0263931901870927	-3.63464924956264	6	3	0.0272727272727273	110	907	38,35,501	ACAT1,ACADS,ALDH7A1
META_PWY66-341	cholesterol biosynthesis I	0.0343714521138468	-3.37052893955559	11	4	0.0363636363636364	110	907	6713,4047,6307,2222	SQLE,LSS,MSMO1,FDFT1
META_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.0343714521138468	-3.37052893955559	11	4	0.0363636363636364	110	907	6713,4047,6307,2222	SQLE,LSS,MSMO1,FDFT1
META_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.0343714521138468	-3.37052893955559	11	4	0.0363636363636364	110	907	6713,4047,6307,2222	SQLE,LSS,MSMO1,FDFT1
META_DETOX1-PWY-1	reactive oxygen species degradation	0.0421591946301253	-3.1663024776325	7	3	0.0272727272727273	110	907	847,2876,6648	CAT,GPX1,SOD2
HUMAN_PWY-6117	spermine and spermidine degradation I	0.0742340929865951	-2.60053176012188	4	2	0.0181818181818182	110	907	196743,6303	PAOX,SAT1
HUMAN_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.0742340929865951	-2.60053176012188	4	2	0.0181818181818182	110	907	51074,84245	APIP,MRI1
META_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.0742340929865951	-2.60053176012188	4	2	0.0181818181818182	110	907	1738,5162	DLD,PDHB
HUMAN_PWY-5177	glutaryl-CoA degradation	0.0742340929865951	-2.60053176012188	4	2	0.0181818181818182	110	907	38,1892	ACAT1,ECHS1
HUMAN_PWY-5659	GDP-mannose biosynthesis	0.0742340929865951	-2.60053176012188	4	2	0.0181818181818182	110	907	4351,29926	MPI,GMPPA
HUMAN_PWY-6755	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.0742340929865951	-2.60053176012188	4	2	0.0181818181818182	110	907	51074,84245	APIP,MRI1
HUMAN_PWY-7112	4-hydroxy-2-nonenal detoxification	0.0742340929865951	-2.60053176012188	4	2	0.0181818181818182	110	907	2941,2950	GSTA4,GSTP1
META_FAO-PWY	fatty acid beta-oxidation I	0.0782998832433092	-2.54720916713197	14	4	0.0363636363636364	110	907	51703,3033,3032,1892	ACSL5,HADH,HADHB,ECHS1
HUMAN_FAO-PWY	fatty acid beta-oxidation	0.0782998832433092	-2.54720916713197	14	4	0.0363636363636364	110	907	51703,3033,1892,3032	ACSL5,HADH,ECHS1,HADHB
META_PWY-6353	purine nucleotides degradation II (aerobic)	0.0844520909958168	-2.47157087587125	9	3	0.0272727272727273	110	907	9615,3615,4907	GDA,IMPDH2,NT5E
HUMAN_DETOX1-PWY-1	reactive oxygen species degradation	0.110324043238553	-2.20433339607303	10	3	0.0272727272727273	110	907	847,2876,6648	CAT,GPX1,SOD2
HUMAN_PWY-6398	melatonin degradation I	0.110324043238553	-2.20433339607303	10	3	0.0272727272727273	110	907	113612,5447,1545	CYP2U1,POR,CYP1B1
HUMAN_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	0.110324043238553	-2.20433339607303	10	3	0.0272727272727273	110	907	51703,60481,6296	ACSL5,ELOVL5,ACSM3
HUMAN_PWY-7180	2'-deoxy-alpha-D-ribose 1-phosphate degradation	0.114079424773902	-2.17086036463337	5	2	0.0181818181818182	110	907	221,55276	ALDH3B1,PGM2
META_PWY-6111	mitochondrial L-carnitine shuttle	0.114079424773902	-2.17086036463337	5	2	0.0181818181818182	110	907	1384,1376	CRAT,CPT2
HUMAN_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.114079424773902	-2.17086036463337	5	2	0.0181818181818182	110	907	1738,5162	DLD,PDHB
META_PWY-6398	melatonin degradation I	0.114079424773902	-2.17086036463337	5	2	0.0181818181818182	110	907	5447,1545	POR,CYP1B1
META_PWY-6402	superpathway of melatonin degradation	0.114079424773902	-2.17086036463337	5	2	0.0181818181818182	110	907	5447,1545	POR,CYP1B1
HUMAN_PWY-6111	mitochondrial L-carnitine shuttle	0.114079424773902	-2.17086036463337	5	2	0.0181818181818182	110	907	1384,1376	CRAT,CPT2
META_PWY-4081	glutathione redox reactions I	0.114079424773902	-2.17086036463337	5	2	0.0181818181818182	110	907	2936,2876	GSR,GPX1
HUMAN_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.114079424773902	-2.17086036463337	5	2	0.0181818181818182	110	907	3615,4907	IMPDH2,NT5E
META_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	2582	GALE
HUMAN_PWY-6132	lanosterol biosynthesis	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	4047	LSS
META_PWY-5326	sulfite oxidation IV	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	6821	SUOX
META_GLUT-REDOX-PWY	glutathione redox reactions II	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	2936	GSR
HUMAN_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	2582	GALE
HUMAN_PWY-7592	arachidonate biosynthesis III (metazoa)	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	60481	ELOVL5
HUMAN_PWY-5326	sulfite oxidation	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	6821	SUOX
HUMAN_PWY0-1305	glutamate dependent acid resistance	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	2752	GLUL
META_GLNSYN-PWY	L-glutamine biosynthesis I	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	2752	GLUL
META_PWY-7592	arachidonate biosynthesis III (metazoa)	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	60481	ELOVL5
META_PWY-7344	UDP-D-galactose biosynthesis	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	2582	GALE
META_PWY-6132	lanosterol biosynthesis	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	4047	LSS
HUMAN_MANNCAT-PWY	D-mannose degradation	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	4351	MPI
HUMAN_GLUT-REDOX-PWY	glutathione redox reactions II	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	2936	GSR
HUMAN_GLNSYN-PWY	glutamine biosynthesis	0.121278941565744	-2.10966208432154	1	1	0.00909090909090909	110	907	2752	GLUL
HUMAN_PWY-6402	superpathway of melatonin degradation	0.138806264910318	-1.97467609568656	11	3	0.0272727272727273	110	907	113612,5447,1545	CYP2U1,POR,CYP1B1
HUMAN_PWY-6857	retinol biosynthesis	0.140396502762122	-1.96328469680236	17	4	0.0363636363636364	110	907	8824,9249,9227,157506	CES2,DHRS3,LRAT,RDH10
META_ILEUDEG-PWY	L-isoleucine degradation I	0.157922542067526	-1.84565060624108	6	2	0.0181818181818182	110	907	38,1738	ACAT1,DLD
HUMAN_PWY-6074	zymosterol biosynthesis	0.157922542067526	-1.84565060624108	6	2	0.0181818181818182	110	907	7108,6307	TM7SF2,MSMO1
META_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.157922542067526	-1.84565060624108	6	2	0.0181818181818182	110	907	3615,4907	IMPDH2,NT5E
HUMAN_PWY-4081	glutathione redox reactions I	0.157922542067526	-1.84565060624108	6	2	0.0181818181818182	110	907	2936,2876	GSR,GPX1
META_PWY-6857	retinol biosynthesis	0.169460679827292	-1.77513435649266	12	3	0.0272727272727273	110	907	9249,9227,157506	DHRS3,LRAT,RDH10
HUMAN_ILEUDEG-PWY	isoleucine degradation	0.169460679827292	-1.77513435649266	12	3	0.0272727272727273	110	907	38,1738,1892	ACAT1,DLD,ECHS1
HUMAN_TRIGLSYN-PWY	triacylglycerol biosynthesis	0.176264682927787	-1.73576853336793	25	5	0.0454545454545455	110	907	10162,57678,8694,84803,8612	LPCAT3,GPAM,DGAT1,GPAT3,PLPP2
HUMAN_PWY-5667	CDP-diacylglycerol biosynthesis	0.189907836330365	-1.66121639645255	19	4	0.0363636363636364	110	907	10162,57678,8760,84803	LPCAT3,GPAM,CDS2,GPAT3
META_PWY-6861	the visual cycle I (vertebrates)	0.201848182336347	-1.60023943674555	13	3	0.0272727272727273	110	907	9249,9227,157506	DHRS3,LRAT,RDH10
HUMAN_PWY66-391	fatty acid beta-oxidation (peroxisome)	0.201848182336347	-1.60023943674555	13	3	0.0272727272727273	110	907	51703,3033,51	ACSL5,HADH,ACOX1
META_PWY-5920	superpathway of heme biosynthesis from glycine	0.204227881042935	-1.58851884465364	7	2	0.0181818181818182	110	907	210,1371	ALAD,CPOX
META_PWY-6872	retinoate biosynthesis I	0.204227881042935	-1.58851884465364	7	2	0.0181818181818182	110	907	8854,220	ALDH1A2,ALDH1A3
HUMAN_PWY-5920	heme biosynthesis	0.204227881042935	-1.58851884465364	7	2	0.0181818181818182	110	907	210,1371	ALAD,CPOX
META_PWY-6076	vitamin D3 biosynthesis	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	5447	POR
META_CHOLINE-BETAINE-ANA-PWY	choline degradation I	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	501	ALDH7A1
HUMAN_PWY-6076	vitamin D3 biosynthesis	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	5447	POR
META_PWY-4041	gamma-glutamyl cycle	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	2730	GCLM
META_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	4522	MTHFD1
HUMAN_PWY-4821	UDP-D-xylose and UDP-D-glucuronate biosynthesis	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	7358	UGDH
META_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	140838	NANP
META_PWY-7511	protein ubiquitylation	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	7317	UBA1
HUMAN_PWY-6370	ascorbate recycling (cytosolic)	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	9446	GSTO1
META_PLPSAL-PWY	pyridoxal 5'-phosphate salvage I	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	8566	PDXK
META_PWY-5030	L-histidine degradation III	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	4522	MTHFD1
HUMAN_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	4522	MTHFD1
HUMAN_PWY-4041	gamma-glutamyl cycle	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	55748	CNDP2
META_LYSINE-DEG1-PWY	L-lysine degradation XI (mammalian)	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	501	ALDH7A1
HUMAN_LYSINE-DEG1-PWY	lysine degradation I (saccharopine pathway)	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	501	ALDH7A1
META_PWY-5177	glutaryl-CoA degradation	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	38	ACAT1
META_PWY-6145	superpathway of sialic acids and CMP-sialic acids biosynthesis	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	140838	NANP
META_PWY-5505	L-glutamate and L-glutamine biosynthesis	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	2752	GLUL
META_PWY-7343	UDP-glucose biosynthesis	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	55276	PGM2
HUMAN_CHOLINE-BETAINE-ANA-PWY	choline degradation	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	501	ALDH7A1
META_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	5238	PGM3
META_PWY-6370	ascorbate recycling (cytosolic)	0.227966928789065	-1.47855470971911	2	1	0.00909090909090909	110	907	9446	GSTO1
HUMAN_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis	0.235543172998312	-1.44586105749401	14	3	0.0272727272727273	110	907	7298,50484,4832	TYMS,RRM2B,NME3
HUMAN_PWY-7228	guanosine nucleotides de novo biosynthesis	0.235543172998312	-1.44586105749401	14	3	0.0272727272727273	110	907	3615,50484,4832	IMPDH2,RRM2B,NME3
HUMAN_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	0.235543172998312	-1.44586105749401	14	3	0.0272727272727273	110	907	7298,50484,4832	TYMS,RRM2B,NME3
HUMAN_PWY-6872	retinoate biosynthesis I	0.251768029057554	-1.37924713502196	8	2	0.0181818181818182	110	907	8854,220	ALDH1A2,ALDH1A3
HUMAN_PWY-6861	the visual cycle I (vertebrates)	0.270143740117194	-1.3088010908384	15	3	0.0272727272727273	110	907	9249,9227,157506	DHRS3,LRAT,RDH10
HUMAN_PWY-6353	purine nucleotides degradation	0.29957258278996	-1.20539854424371	9	2	0.0181818181818182	110	907	3615,4907	IMPDH2,NT5E
HUMAN_PWY-0	putrescine degradation III	0.29957258278996	-1.20539854424371	9	2	0.0181818181818182	110	907	221,6303	ALDH3B1,SAT1
HUMAN_PWY-7527	methionine salvage cycle III	0.29957258278996	-1.20539854424371	9	2	0.0181818181818182	110	907	51074,84245	APIP,MRI1
HUMAN_PWY-5331	taurine biosynthesis	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	84890	ADO
META_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	1738	DLD
META_PWY-5331	taurine biosynthesis	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	84890	ADO
META_ARGININE-SYN4-PWY	L-ornithine de novo  biosynthesis	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	4942	OAT
META_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	60481	ELOVL5
META_MALATE-ASPARTATE-SHUTTLE-PWY	L-aspartate degradation II	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	4190	MDH1
HUMAN_PWY-4202	arsenate detoxification I (glutaredoxin)	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	9446	GSTO1
META_GLYCLEAV-PWY	glycine cleavage	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	1738	DLD
HUMAN_PWY-6100	L-carnitine biosynthesis	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	223	ALDH9A1
HUMAN_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	1738	DLD
META_PWY0-1296	purine ribonucleosides degradation	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	55276	PGM2
META_ARGASEDEG-PWY	L-arginine degradation I (arginase pathway)	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	4942	OAT
HUMAN_PWY0-1182	trehalose degradation	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	130589	GALM
META_PWY-6100	L-carnitine biosynthesis	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	223	ALDH9A1
HUMAN_PWY66-385	dTMP de novo biosynthesis (mitochondrial)	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	7298	TYMS
META_HEME-BIOSYNTHESIS-II	heme biosynthesis I (aerobic)	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	1371	CPOX
META_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	60481	ELOVL5
META_PWY66-425	L-lysine degradation II (L-pipecolate pathway)	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	501	ALDH7A1
HUMAN_NONOXIPENT-PWY	pentose phosphate pathway (non-oxidative branch)	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	7086	TKT
HUMAN_ARGININE-SYN4-PWY	ornithine de novo  biosynthesis	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	4942	OAT
META_PWY-4202	arsenate detoxification I (glutaredoxin)	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	9446	GSTO1
HUMAN_PWY0-1296	purine ribonucleosides degradation to ribose-1-phosphate	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	55276	PGM2
HUMAN_GLYCLEAV-PWY	glycine cleavage	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	1738	DLD
HUMAN_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	1371	CPOX
HUMAN_GLUDEG-I-PWY	GABA shunt	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	2752	GLUL
META_GLYCINE-SYN2-PWY	glycine biosynthesis II	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	1738	DLD
HUMAN_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.321805202640355	-1.13380887724455	3	1	0.00909090909090909	110	907	60481	ELOVL5
HUMAN_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	0.346884717678401	-1.05876277994512	10	2	0.0181818181818182	110	907	50484,4832	RRM2B,NME3
HUMAN_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis	0.346884717678401	-1.05876277994512	10	2	0.0181818181818182	110	907	50484,4832	RRM2B,NME3
HUMAN_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.393124373848747	-0.933629244282285	11	2	0.0181818181818182	110	907	3615,4832	IMPDH2,NME3
HUMAN_LEU-DEG2-PWY	leucine degradation	0.393124373848747	-0.933629244282285	11	2	0.0181818181818182	110	907	1738,3712	DLD,IVD
META_PWY66-368	ketolysis	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	38	ACAT1
META_PWY-5189	tetrapyrrole biosynthesis II (from glycine)	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	210	ALAD
HUMAN_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	1738	DLD
HUMAN_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	3422	IDI1
HUMAN_PWY-2161	folate polyglutamylation	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	4522	MTHFD1
META_PWY-3781	aerobic respiration I (cytochrome c)	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	6389	SDHA
META_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	1738	DLD
HUMAN_PWY66-368	ketolysis	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	38	ACAT1
HUMAN_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	51363	CHST15
META_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	3422	IDI1
HUMAN_PWY66-367	ketogenesis	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	38	ACAT1
META_PWY66-162	ethanol degradation IV	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	847	CAT
META_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	55191	NADSYN1
META_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	1890	TYMP
META_PWY-6608	guanosine nucleotides degradation III	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	9615	GDA
HUMAN_MALATE-ASPARTATE-SHUTTLE-PWY	malate-aspartate shuttle	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	4190	MDH1
HUMAN_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	55191	NADSYN1
META_PWY-5661	GDP-glucose biosynthesis	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	55276	PGM2
HUMAN_PWY66-387	fatty acid alpha-oxidation	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	5264	PHYH
META_PWY-6061	bile acid biosynthesis, neutral pathway	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	5447	POR
META_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	51363	CHST15
HUMAN_PWY-5661-1	GDP-glucose biosynthesis II	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	55276	PGM2
HUMAN_PWY-5189	tetrapyrrole biosynthesis	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	210	ALAD
HUMAN_PWY66-425	lysine degradation II (pipecolate pathway)	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	501	ALDH7A1
HUMAN_THIOREDOX-PWY	thioredoxin pathway	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	25824	PRDX5
META_PWY66-387	fatty acid alpha-oxidation II	0.404328905859632	-0.905526608824766	4	1	0.00909090909090909	110	907	5264	PHYH
HUMAN_PWY-4061	glutathione-mediated detoxification	0.410700943059864	-0.889889961796637	19	3	0.0272727272727273	110	907	2941,373156,2950	GSTA4,GSTK1,GSTP1
META_PWY-6368	3-phosphoinositide degradation	0.410700943059864	-0.889889961796637	19	3	0.0272727272727273	110	907	3636,3635,8821	INPPL1,INPP5D,INPP4B
META_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	0.437857112653771	-0.825862648647109	12	2	0.0181818181818182	110	907	51703,51	ACSL5,ACOX1
HUMAN_VALDEG-PWY	valine degradation	0.437857112653771	-0.825862648647109	12	2	0.0181818181818182	110	907	1738,1892	DLD,ECHS1
HUMAN_PWY-6000	gamma-linolenate biosynthesis	0.437857112653771	-0.825862648647109	12	2	0.0181818181818182	110	907	51703,6296	ACSL5,ACSM3
HUMAN_PWY-6368	3-phosphoinositide degradation	0.444969507518855	-0.809749521593205	20	3	0.0272727272727273	110	907	3636,3635,8821	INPPL1,INPP5D,INPP4B
HUMAN_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.444969507518855	-0.809749521593205	20	3	0.0272727272727273	110	907	7298,50484,4832	TYMS,RRM2B,NME3
META_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	7298	TYMS
HUMAN_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	1890	TYMP
HUMAN_PWY66-375	leukotriene biosynthesis	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	4048	LTA4H
META_CITRULBIO-PWY	L-citrulline biosynthesis	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	4942	OAT
META_PWY66-375	leukotriene biosynthesis	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	4048	LTA4H
META_PWY-6566	chondroitin biosynthesis	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	79586	CHPF
HUMAN_PWY-6566	chondroitin and dermatan biosynthesis	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	79586	CHPF
META_TYRFUMCAT-PWY	L-tyrosine degradation I	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	2184	FAH
META_PWY66-367	ketogenesis	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	38	ACAT1
META_SALVADEHYPOX-PWY	adenosine nucleotides degradation II	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	4907	NT5E
HUMAN_TYRFUMCAT-PWY	tyrosine degradation	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	2184	FAH
META_PWY-6074	zymosterol biosynthesis	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	6307	MSMO1
META_VALDEG-PWY	L-valine degradation I	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	1738	DLD
HUMAN_PWY66-162	ethanol degradation IV	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	847	CAT
HUMAN_PLPSAL-PWY	pyridoxal 5'-phosphate salvage	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	8566	PDXK
HUMAN_PWY66-241	bupropion degradation	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	113612	CYP2U1
HUMAN_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	9945	GFPT2
HUMAN_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	7298	TYMS
HUMAN_PWY-5030	histidine degradation	0.476891276132172	-0.740466746711344	5	1	0.00909090909090909	110	907	4522	MTHFD1
HUMAN_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.48076782725789	-0.732370813021076	13	2	0.0181818181818182	110	907	51363,79586	CHST15,CHPF
HUMAN_PWY66-407	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	0.49782499739249	-0.697506674575203	38	5	0.0454545454545455	110	907	4190,5211,1738,5162,6389	MDH1,PFKL,DLD,PDHB,SDHA
HUMAN_PWY-5328	superpathway of methionine degradation	0.521638602967666	-0.650780262351179	14	2	0.0181818181818182	110	907	6821,1738	SUOX,DLD
META_PWY-5328	superpathway of L-methionine salvage and degradation	0.521638602967666	-0.650780262351179	14	2	0.0181818181818182	110	907	6821,1738	SUOX,DLD
HUMAN_PWY3DJ-12	ceramide de novo biosynthesis	0.540685022946695	-0.61491838235511	6	1	0.00909090909090909	110	907	9517	SPTLC2
META_PWY66-428	L-threonine degradation V	0.540685022946695	-0.61491838235511	6	1	0.00909090909090909	110	907	1738	DLD
META_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.540685022946695	-0.61491838235511	6	1	0.00909090909090909	110	907	3615	IMPDH2
META_PWY66-373	sucrose degradation V (sucrose alpha-glucosidase)	0.540685022946695	-0.61491838235511	6	1	0.00909090909090909	110	907	130589	GALM
HUMAN_PWY3O-450	phosphatidylcholine biosynthesis	0.540685022946695	-0.61491838235511	6	1	0.00909090909090909	110	907	1119	CHKA
HUMAN_PWY-5143	fatty acid activation	0.540685022946695	-0.61491838235511	6	1	0.00909090909090909	110	907	51703	ACSL5
META_PWY3DJ-12	ceramide de novo biosynthesis	0.540685022946695	-0.61491838235511	6	1	0.00909090909090909	110	907	9517	SPTLC2
HUMAN_PENTOSE-P-PWY	pentose phosphate pathway	0.540685022946695	-0.61491838235511	6	1	0.00909090909090909	110	907	7086	TKT
META_PWY-7277	sphingolipid biosynthesis (mammals)	0.540685022946695	-0.61491838235511	6	1	0.00909090909090909	110	907	9517	SPTLC2
HUMAN_PWY66-428	threonine degradation	0.540685022946695	-0.61491838235511	6	1	0.00909090909090909	110	907	1738	DLD
HUMAN_PWY-6571	dermatan sulfate biosynthesis	0.560330120330175	-0.57922916835056	15	2	0.0181818181818182	110	907	51363,79586	CHST15,CHPF
META_PWY-6571	dermatan sulfate biosynthesis	0.560330120330175	-0.57922916835056	15	2	0.0181818181818182	110	907	51363,79586	CHST15,CHPF
HUMAN_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.560330120330175	-0.57922916835056	15	2	0.0181818181818182	110	907	3636,3635	INPPL1,INPP5D
META_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.560330120330175	-0.57922916835056	15	2	0.0181818181818182	110	907	3636,3635	INPPL1,INPP5D
HUMAN_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.560330120330175	-0.57922916835056	15	2	0.0181818181818182	110	907	3636,3635	INPPL1,INPP5D
META_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.560330120330175	-0.57922916835056	15	2	0.0181818181818182	110	907	3636,3635	INPPL1,INPP5D
HUMAN_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.560330120330175	-0.57922916835056	15	2	0.0181818181818182	110	907	7298,4832	TYMS,NME3
META_LEU-DEG2-PWY	L-leucine degradation I	0.596761213265712	-0.51623822338136	7	1	0.00909090909090909	110	907	1738	DLD
HUMAN_PWY66-221	nicotine degradation III	0.596761213265712	-0.51623822338136	7	1	0.00909090909090909	110	907	113612	CYP2U1
HUMAN_SALVADEHYPOX-PWY	adenosine nucleotides degradation	0.596761213265712	-0.51623822338136	7	1	0.00909090909090909	110	907	4907	NT5E
META_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.596761213265712	-0.51623822338136	7	1	0.00909090909090909	110	907	51363	CHST15
HUMAN_PWY66-414	superpathway of choline degradation to L-serine	0.596761213265712	-0.51623822338136	7	1	0.00909090909090909	110	907	501	ALDH7A1
META_PWY-5130	2-oxobutanoate degradation I	0.596761213265712	-0.51623822338136	7	1	0.00909090909090909	110	907	1738	DLD
HUMAN_PWY66-373	sucrose degradation	0.596761213265712	-0.51623822338136	7	1	0.00909090909090909	110	907	130589	GALM
HUMAN_PWY-5067	glycogen biosynthesis	0.596761213265712	-0.51623822338136	7	1	0.00909090909090909	110	907	55276	PGM2
HUMAN_PWY-5130	2-oxobutanoate degradation	0.596761213265712	-0.51623822338136	7	1	0.00909090909090909	110	907	1738	DLD
META_PWY66-398	TCA cycle III (animals)	0.596766078384191	-0.516230070876573	16	2	0.0181818181818182	110	907	4190,6389	MDH1,SDHA
HUMAN_PWY66-398	TCA cycle	0.596766078384191	-0.516230070876573	16	2	0.0181818181818182	110	907	4190,6389	MDH1,SDHA
HUMAN_PWY66-401	superpathway of tryptophan utilization	0.60795417969163	-0.497655762205147	34	4	0.0363636363636364	110	907	55191,113612,5447,1545	NADSYN1,CYP2U1,POR,CYP1B1
HUMAN_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.630920188561035	-0.460575908496118	17	2	0.0181818181818182	110	907	79837,5331	PIP4K2C,PLCB3
META_PWY-7426	mannosyl-glycoprotein N-acetylglucosaminyltransferases	0.646045953867766	-0.436884641711369	8	1	0.00909090909090909	110	907	4245	MGAT1
META_TRYPTOPHAN-DEGRADATION-1	L-tryptophan degradation III (eukaryotic)	0.646045953867766	-0.436884641711369	8	1	0.00909090909090909	110	907	38	ACAT1
HUMAN_PWY-5451	acetone degradation I (to methylglyoxal)	0.646045953867766	-0.436884641711369	8	1	0.00909090909090909	110	907	113612	CYP2U1
HUMAN_PWY-2201	folate transformations I	0.646045953867766	-0.436884641711369	8	1	0.00909090909090909	110	907	4522	MTHFD1
HUMAN_PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	0.646045953867766	-0.436884641711369	8	1	0.00909090909090909	110	907	2582	GALE
META_PWY-7228	superpathway of guanosine nucleotides de novo biosynthesis I	0.646045953867766	-0.436884641711369	8	1	0.00909090909090909	110	907	3615	IMPDH2
META_PWY-6569	chondroitin sulfate biosynthesis	0.662805352934988	-0.41127391721764	18	2	0.0181818181818182	110	907	51363,79586	CHST15,CHPF
HUMAN_PWY-841	purine nucleotides de novo biosynthesis	0.676990135930797	-0.390098576440711	37	4	0.0363636363636364	110	907	3615,50484,4832,10476	IMPDH2,RRM2B,NME3,ATP5H
HUMAN_PWY-7511	protein ubiquitylation	0.680960659068949	-0.384250743856773	28	3	0.0272727272727273	110	907	65264,7317,9039	UBE2Z,UBA1,UBA3
HUMAN_MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS	dolichyl-diphosphooligosaccharide biosynthesis	0.689355125254331	-0.371998719483411	9	1	0.00909090909090909	110	907	1798	DPAGT1
META_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	0.689355125254331	-0.371998719483411	9	1	0.00909090909090909	110	907	7298	TYMS
META_NADSYN-PWY	NAD biosynthesis II (from tryptophan)	0.689355125254331	-0.371998719483411	9	1	0.00909090909090909	110	907	55191	NADSYN1
HUMAN_PWY-7205	CMP phosphorylation	0.689355125254331	-0.371998719483411	9	1	0.00909090909090909	110	907	4832	NME3
META_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis I	0.689355125254331	-0.371998719483411	9	1	0.00909090909090909	110	907	7298	TYMS
HUMAN_PWY-6569	chondroitin sulfate biosynthesis	0.692464695273749	-0.3674980237744	19	2	0.0181818181818182	110	907	51363,79586	CHST15,CHPF
META_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.692464695273749	-0.3674980237744	19	2	0.0181818181818182	110	907	3636,3635	INPPL1,INPP5D
HUMAN_PWY66-409	superpathway of purine nucleotide salvage	0.698068387523191	-0.359438204624881	38	4	0.0363636363636364	110	907	3615,50484,10476,4832	IMPDH2,RRM2B,ATP5H,NME3
HUMAN_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.719964160580244	-0.328553845182834	20	2	0.0181818181818182	110	907	3636,3635	INPPL1,INPP5D
META_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.727407392764176	-0.318268583208725	10	1	0.00909090909090909	110	907	7298	TYMS
HUMAN_PWY66-201	nicotine degradation IV	0.727407392764176	-0.318268583208725	10	1	0.00909090909090909	110	907	113612	CYP2U1
HUMAN_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.727407392764176	-0.318268583208725	10	1	0.00909090909090909	110	907	4832	NME3
META_PWY-5004	superpathway of L-citrulline metabolism	0.760835694656066	-0.273337851585415	11	1	0.00909090909090909	110	907	4942	OAT
HUMAN_PWY-5972	stearate biosynthesis	0.760835694656066	-0.273337851585415	11	1	0.00909090909090909	110	907	51703	ACSL5
HUMAN_PWY-7224	purine deoxyribonucleosides salvage	0.760835694656066	-0.273337851585415	11	1	0.00909090909090909	110	907	4832	NME3
HUMAN_PWY-7176	UTP and CTP de novo biosynthesis	0.760835694656066	-0.273337851585415	11	1	0.00909090909090909	110	907	4832	NME3
HUMAN_NADSYN-PWY	NAD de novo biosynthesis	0.760835694656066	-0.273337851585415	11	1	0.00909090909090909	110	907	55191	NADSYN1
HUMAN_PWY-6061	bile acid biosynthesis, neutral pathway	0.79019738393126	-0.235472511651607	12	1	0.00909090909090909	110	907	5447	POR
HUMAN_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.790385118652531	-0.235234960341446	23	2	0.0181818181818182	110	907	79837,5331	PIP4K2C,PLCB3
HUMAN_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	0.815983180322173	-0.203361536580746	13	1	0.00909090909090909	110	907	4832	NME3
META_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.815983180322173	-0.203361536580746	13	1	0.00909090909090909	110	907	7298	TYMS
META_PWY-841	superpathway of purine nucleotides de novo biosynthesis I	0.815983180322173	-0.203361536580746	13	1	0.00909090909090909	110	907	3615	IMPDH2
META_PWY66-409	superpathway of purine nucleotide salvage	0.815983180322173	-0.203361536580746	13	1	0.00909090909090909	110	907	3615	IMPDH2
HUMAN_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.815983180322173	-0.203361536580746	13	1	0.00909090909090909	110	907	3636	INPPL1
META_PWY-6352	3-phosphoinositide biosynthesis	0.828291029034825	-0.188390702011452	25	2	0.0181818181818182	110	907	5295,5290	PIK3R1,PIK3CA
HUMAN_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.828291029034825	-0.188390702011452	25	2	0.0181818181818182	110	907	6483,55568	ST3GAL2,GALNT10
HUMAN_PWY-6371	superpathway of inositol phosphate compounds	0.836697145911347	-0.178293106811839	66	6	0.0545454545454545	110	907	3636,3635,5295,79837,5290,5331	INPPL1,INPP5D,PIK3R1,PIP4K2C,PIK3CA,PLCB3
META_ANAEROFRUCAT-PWY	homolactic fermentation	0.858503281644696	-0.152564776118778	15	1	0.00909090909090909	110	907	5211	PFKL
HUMAN_PWY-6352	3-phosphoinositide biosynthesis	0.859970237811636	-0.150857497529199	27	2	0.0181818181818182	110	907	5295,5290	PIK3R1,PIK3CA
HUMAN_PWY66-399	gluconeogenesis	0.875952428529707	-0.132443494851718	16	1	0.00909090909090909	110	907	4190	MDH1
META_PWY66-399	gluconeogenesis III	0.875952428529707	-0.132443494851718	16	1	0.00909090909090909	110	907	4190	MDH1
META_PWY66-400	glycolysis VI (metazoan)	0.89126694352996	-0.11511129646103	17	1	0.00909090909090909	110	907	5211	PFKL
HUMAN_PWY66-400	glycolysis	0.89126694352996	-0.11511129646103	17	1	0.00909090909090909	110	907	5211	PFKL
HUMAN_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.916497036479037	-0.087196445227477	19	1	0.00909090909090909	110	907	10476	ATP5H
HUMAN_LIPASYN-PWY	phospholipases	0.977908126976139	-0.022339553057129	29	1	0.00909090909090909	110	907	5331	PLCB3
HUMAN_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-6620	guanine and guanosine salvage	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6405	Rapoport-Luebering glycolytic shunt	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6129	dolichol and dolichyl phosphate biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY0-662	PRPP biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_GLYSYN-ALA-PWY	glycine biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY66-397	resolvin D biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6118	glycerol-3-phosphate shuttle	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PROSYN-PWY	proline biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY0-1295	pyrimidine ribonucleosides degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY66-301	catecholamine biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_BETA-ALA-DEGRADATION-I-PWY	beta-alanine degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY66-366	flavin biosynthesis IV (mammalian)	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-5874	heme degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY6666-1	anandamide degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY3O-4106	NAD salvage pathway III	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6620	guanine and guanosine salvage	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-5905	hypusine biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-6118	glycerol-3-phosphate shuttle	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-5686	UMP biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY66-397	resolvin D biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6241	thyroid hormone biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-5525	D-glucuronate degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-5481	lactate fermentation (reoxidation of cytosolic NADH)	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY66-14	MAP kinase cascade	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_ASPARTATESYN-PWY	aspartate biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY0-1275	lipoate biosynthesis and incorporation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_GLUTAMINDEG-PWY	glutamine degradation/glutamate biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-5386	methylglyoxal degradation I	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-6124	inosine-5'-phosphate biosynthesis II	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_FASYN-ELONG-PWY	fatty acid elongation -- saturated	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_SER-GLYSYN-PWY	superpathway of L-serine and glycine biosynthesis I	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6124	inosine-5'-phosphate biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY66-380	estradiol biosynthesis I (via estrone)	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6012-1	acyl carrier protein metabolism	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6482	diphthamide biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PROSYN-PWY	L-proline biosynthesis I	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_CYSTEINE-DEG-PWY	L-cysteine degradation I	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-5269	cardiolipin biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6181	histamine degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY0-662	PRPP biosynthesis I	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_SERDEG-PWY	L-serine degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_GLUDEG-I-PWY	GABA shunt	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-6307	L-tryptophan degradation X (mammalian, via tryptamine)	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY66-388	fatty acid alpha-oxidation III	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-5453	methylglyoxal degradation III	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PROUT-PWY	L-proline degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_GLYSYN-PWY	glycine/serine biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-1801	formaldehyde oxidation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6	GDP-L-fucose biosynthesis II (from L-fucose)	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-5137	fatty acid beta-oxidation (unsaturated, odd number)	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-7306	estradiol biosynthesis II	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_ASPARAGINE-BIOSYNTHESIS	asparagine biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-2301	myo-inositol de novo biosynthesis	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
HUMAN_PWY-6608	guanosine nucleotides degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-6181	histamine degradation	0.999999999995681	-4.31945278156487e-12	2	0	0	110	907
META_PWY-6823	molybdenum cofactor biosynthesis	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY66-423	fructose 2,6-bisphosphate biosynthesis	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY-7434	terminal O-glycans residues modification	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY6666-2	dopamine degradation	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_2PHENDEG-PWY	phenylethylamine degradation I	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_HYDROXYPRODEG-PWY	4-hydroxyproline degradation	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY-6405	Rapoport-Luebering glycolytic shunt	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY-7205	CMP phosphorylation	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-6158	creatine-phosphate biosynthesis	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY66-21	ethanol degradation II	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-7177	UTP and CTP dephosphorylation II	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-6292	cysteine biosynthesis	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY-6158	creatine-phosphate biosynthesis	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_ASPARAGINE-DEG1-PWY-1	asparagine degradation	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_HYDROXYPRODEG-PWY	trans-4-hydroxy-L-proline degradation I	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_POLYAMINSYN3-PWY	superpathway of polyamine biosynthesis II	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY-6318	L-phenylalanine degradation IV (mammalian, via side chain)	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-4921	protein citrullination	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY66-423	fructose 2,6-bisphosphate synthesis	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_SER-GLYSYN-PWY	serine and glycine biosynthesis	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY66-161	oxidative ethanol degradation III	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-5874	heme degradation	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-4984	urea cycle	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-5872	ubiquinol-10 biosynthesis	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-6823	molybdenum cofactor biosynthesis	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-6307	tryptophan degradation via tryptamine	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY-5994	palmitate biosynthesis I (animals and fungi)	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-6517	N-acetylglucosamine degradation II	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-4261	glycerol degradation	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
HUMAN_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	0.999999999999142	-8.57505445773718e-13	4	0	0	110	907
META_PWY66-382	mineralocorticoid biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PROPIONMET-PWY	propionyl-CoA degradation	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_ADENOSYLHOMOCYSCAT-PWY	L-methionine salvage from L-homocysteine	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-5996	oleate biosynthesis II (animals and fungi)	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-5664	tetrahydrobiopterin biosynthesis II	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY-7193	pyrimidine ribonucleosides salvage I	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-6609	adenine and adenosine salvage III	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PROPIONMET-PWY	propanoyl CoA degradation I	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY66-381	glucocorticoid biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY0-1295	pyrimidine ribonucleosides degradation	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY66-388	fatty acid alpha-oxidation III	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_ASPARAGINE-DEG1-PWY-1	L-asparagine degradation III (mammalian)	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-6000	gamma-linolenate biosynthesis II (animals)	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY66-392	lipoxin biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY6666-2	dopamine degradation	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY-6875	retinoate biosynthesis II	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY66-382	mineralocorticoid biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_ADENOSYLHOMOCYSCAT-PWY	methionine salvage	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY-6430	thymine degradation	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_OXIDATIVEPENT-PWY-1	pentose phosphate pathway (oxidative branch)	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY66-381	glucocorticoid biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY66-301	catecholamine biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-6875	retinoate biosynthesis II	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY-7185	UTP and CTP dephosphorylation I	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY-3982	uracil degradation	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_METHIONINE-DEG1-PWY	methionine degradation	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-0	putrescine degradation III	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-5451	acetone degradation I (to methylglyoxal)	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-5663	tetrahydrobiopterin biosynthesis I	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_NAD-BIOSYNTHESIS-III	NAD salvage	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY-5663	tetrahydrobiopterin de novo biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-2301	myo-inositol biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PHENYLALANINE-DEG1-PWY	L-phenylalanine degradation I (aerobic)	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-7193	pyrimidine ribonucleosides salvage I	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-7177	UTP and CTP dephosphorylation II	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-7527	L-methionine salvage cycle III	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_OXIDATIVEPENT-PWY	pentose phosphate pathway (oxidative branch)	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY-6609	adenine and adenosine salvage III	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_GLUAMCAT-PWY	N-acetylglucosamine degradation I	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-3982	uracil degradation I (reductive)	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-7466	acetone degradation III (to propane-1,2-diol)	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PHENYLALANINE-DEG1-PWY	phenylalanine degradation/tyrosine biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_SAM-PWY	S-adenosyl-L-methionine biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY-5453	methylglyoxal degradation III	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY0-1264	biotin-carboxyl carrier protein assembly	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY66-221	nicotine degradation V	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY66-392	lipoxin biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
HUMAN_PWY-7283	wybutosine biosynthesis	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-7185	UTP and CTP dephosphorylation I	0.99999999999928	-7.19537927504343e-13	3	0	0	110	907
META_PWY-6756	S-methyl-5'-thioadenosine degradation II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-7625	phosphatidylinositol biosynthesis II (eukaryotes)	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6292	superpathway of L-cysteine biosynthesis (mammalian)	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6133	(S)-reticuline biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY66-421	homocarnosine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-5329	L-cysteine degradation III	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_P121-PWY	adenine and adenosine salvage I	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_ASPARTATESYN-PWY	L-aspartate biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6273	phosphatidylethanolamine biosynthesis III	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-5686	UMP biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_ALANINE-SYN2-PWY	L-alanine biosynthesis II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-5148	acyl-CoA hydrolysis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6399	melatonin degradation II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-5905	hypusine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-5966	fatty acid biosynthesis initiation II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-46	putrescine biosynthesis III	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6898	thiamin salvage III	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY0-522	lipoate salvage	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-5120	geranylgeranyldiphosphate biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6377	alpha-tocopherol degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY66-389	phytol degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-5754	4-hydroxybenzoate biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_BGALACT-PWY	lactose degradation III	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-40	putrescine biosynthesis II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6012-1	acyl carrier protein metabolism II (mammalian)	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6938	NADH repair	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PROUT-PWY	proline degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-7219	adenosine ribonucleotides de novo biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-5120	geranylgeranyl diphosphate biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-7299	progesterone biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_HOMOCYSDEGR-PWY	cysteine biosynthesis/homocysteine degradation (trans-sulfuration)	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-5754	4-hydroxybenzoate biosynthesis I (eukaryotes)	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-4101	sorbitol degradation I	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_SERDEG-PWY	L-serine degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-7112	4-hydroxy-2-nonenal detoxification	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-40	putrescine biosynthesis I	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-7306	estradiol biosynthesis II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-7299	progesterone biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6619	adenine and adenosine salvage VI	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY66-421	homocarnosine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-5766	L-glutamate degradation X	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6173	histamine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6756	S-methyl-5'-thioadenosine degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY66-241	bupropion degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_GLUTAMATE-SYN2-PWY	glutamate biosynthesis/degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY66-366	flavin biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY66-420	carnosine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_GLUTAMATE-SYN2-PWY	L-glutamate biosynthesis II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_HISHP-PWY	L-histidine degradation VI	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_ALANINE-DEG3-PWY	L-alanine degradation III	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6938	NADH repair	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_BSUBPOLYAMSYN-PWY	spermidine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY66-426	hydrogen sulfide biosynthesis (trans-sulfuration)	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY6666-1	anandamide degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY66-420	carnosine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-46	putrescine biosynthesis I	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6535	4-aminobutyrate degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-5172	acetyl-CoA biosynthesis III (from citrate)	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6173	histamine biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6481	L-dopachrome biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-5329	L-cysteine degradation II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-5963	thio-molybdenum cofactor biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY0-1313	acetate conversion to acetyl-CoA	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6377	alpha-tocopherol degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY0-1021	L-alanine biosynthesis III	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_ALANINE-DEG3-PWY	alanine biosynthesis/degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_SERSYN-PWY	serine biosynthesis (phosphorylated route)	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6134	L-tyrosine biosynthesis IV	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation II (mammalian)	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-5269	cardiolipin biosynthesis II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-5172	acetyl-CoA biosynthesis from citrate	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY66-389	phytol degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6481	L-dopachrome biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-7435	mucin core 3 and core 4 O-glycosylation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6241	thyroid hormone biosynthesis	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6535	4-aminobutanoate degradation I	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6619	adenine and adenosine salvage II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-6334	L-dopa degradation	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY66-11	BMP Signalling Pathway	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY-2161B	glutamate removal from folates	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
META_PWY-6133	(S)-reticuline biosynthesis II	1.00000000000014	1.39471767468535e-13	1	0	0	110	907
HUMAN_PWY66-380	estradiol biosynthesis I	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-5667	CDP-diacylglycerol biosynthesis I	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
HUMAN_PWY-4983	citrulline-nitric oxide cycle	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis I	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-7433	mucin core 1 and core 2 O-glycosylation	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
HUMAN_PWY-3661-1	glycine betaine degradation	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
HUMAN_COA-PWY-1	coenzyme A biosynthesis	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-3661-1	glycine betaine degradation II (mammalian)	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
HUMAN_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
HUMAN_PWY4FS-6	phosphatidylethanolamine biosynthesis II	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-6313	serotonin degradation	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-4983	L-citrulline-nitric oxide cycle	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-5651	L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY66-201	nicotine degradation IV	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
HUMAN_PWY66-21	ethanol degradation II	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-4061	glutathione-mediated detoxification I	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_COA-PWY-1	coenzyme A biosynthesis II (mammalian)	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-4921	protein citrullination	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-4984	urea cycle	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
HUMAN_PWY-5966-1	fatty acid biosynthesis initiation	1.00000000000036	3.58156226573127e-13	5	0	0	110	907
META_PWY-5972	stearate biosynthesis I (animals and fungi)	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
META_PWY-6342	noradrenaline and adrenaline degradation	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
META_PWY66-378	androgen biosynthesis	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
HUMAN_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
META_PWY-7229	superpathway of adenosine nucleotides de novo biosynthesis I	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
HUMAN_PWY-5996	oleate biosynthesis	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
HUMAN_PWY66-161	oxidative ethanol degradation III	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
HUMAN_PWY66-378	androgen biosynthesis	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
META_PWY-7176	UTP and CTP de novo biosynthesis	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
HUMAN_PWY-7455	allopregnanolone biosynthesis	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
META_PWY-7455	allopregnanolone biosynthesis	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
HUMAN_PWY-7209	pyrimidine ribonucleosides degradation	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
META_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	1.00000000000191	1.91222528466545e-12	6	0	0	110	907
HUMAN_PWY3DJ-11281	sphingomyelin metabolism/ceramide salvage	1.00000000000343	3.43370470950753e-12	7	0	0	110	907
HUMAN_PWY66-374	C20 prostanoid biosynthesis	1.00000000000343	3.43370470950753e-12	7	0	0	110	907
META_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1.00000000000343	3.43370470950753e-12	7	0	0	110	907
HUMAN_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000343	3.43370470950753e-12	7	0	0	110	907
META_PWY-7224	purine deoxyribonucleosides salvage	1.00000000000343	3.43370470950753e-12	7	0	0	110	907
HUMAN_PWY-5994	palmitate biosynthesis	1.00000000000343	3.43370470950753e-12	7	0	0	110	907
META_PWY66-374	C20 prostanoid biosynthesis	1.00000000000343	3.43370470950753e-12	7	0	0	110	907
HUMAN_PWY-6369	inositol pyrophosphates biosynthesis	1.00000000000343	3.43370470950753e-12	7	0	0	110	907
META_PWY-6369	inositol pyrophosphates biosynthesis	1.00000000000343	3.43370470950753e-12	7	0	0	110	907
HUMAN_PWY-6313	serotonin degradation	1.00000000000343	3.43370470950753e-12	7	0	0	110	907
HUMAN_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation	1.0000000000041	4.09828382214168e-12	8	0	0	110	907
HUMAN_PWY-7434	terminal O-glycans residues modification	1.0000000000041	4.09828382214168e-12	8	0	0	110	907
META_PWY-6367	D-myo-inositol-5-phosphate metabolism	1.00000000000569	5.68780536902001e-12	9	0	0	110	907
META_PWY-6309	L-tryptophan degradation XI (mammalian, via kynurenine)	1.00000000000569	5.68780536902001e-12	9	0	0	110	907
HUMAN_PWY3DJ-11470	sphingosine and sphingosine-1-phosphate metabolism	1.00000000000569	5.68780536902001e-12	9	0	0	110	907
HUMAN_PWY-6342	noradrenaline and adrenaline degradation	1.00000000000727	7.26842785616349e-12	10	0	0	110	907
META_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000000756	7.56417852020548e-12	11	0	0	110	907
HUMAN_PWY-6309	L-kynurenine degradation	1.00000000000756	7.56417852020548e-12	11	0	0	110	907
META_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	1.00000000000756	7.56417852020548e-12	11	0	0	110	907
HUMAN_LIPAS-PWY	triacylglycerol degradation	1.00000000000756	7.56417852020548e-12	11	0	0	110	907
META_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	1.00000000001095	1.09489025118984e-11	13	0	0	110	907
HUMAN_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000001133	1.13276445482322e-11	14	0	0	110	907
META_PWY-6558	heparan sulfate biosynthesis (late stages)	1.00000000001674	1.67398818663418e-11	17	0	0	110	907
HUMAN_PWY-6558	heparan sulfate biosynthesis (late stages)	1.00000000002027	2.0265679630349e-11	20	0	0	110	907
META_PWY-6564	heparan sulfate biosynthesis	1.00000000002168	2.16826134730121e-11	23	0	0	110	907
HUMAN_PWY-6564	heparan sulfate biosynthesis	1.00000000002563	2.56252319706486e-11	26	0	0	110	907
